The global CD Antigen Cancer Therapy Market is valued at USD 27.5 Billion in 2024 and is projected to reach a value of USD 54 ...

A newly developed radiolabeled antibody that targets the cancer antigen IL13Rα2 has been found to be highly specific, binding ...

Converging computational and laboratory technologies are helping anti-cancer immune responses hit their target more ...

Black and American Indian women with ovarian cancer were less likely to have elevated cancer antigen 125 (CA-125) levels at ...

An Indian biotech start-up led by a Kashmir scientist has a patented, 3rd-generation CAR-T therapy that targets cancer ...

BBC presenter Nick Owen has reflected on his cancer diagnosis calling it “the worst day of my life”. The 77-year-old news ...

triggering an antigen-specific immune response. The activated T cells migrate to tumor tissues, recognize and kill the cancer cells expressing the target antigens. In preclinical studies, EVM14 ...

A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...